scholarly article | Q13442814 |
P356 | DOI | 10.1007/S10147-017-1126-X |
P698 | PubMed publication ID | 28439676 |
P2093 | author name string | Masaki Hashimoto | |
Takashi Nakano | |||
Seiki Hasegawa | |||
Nobuyuki Kondo | |||
Seiji Matsumoto | |||
Teruhisa Takuwa | |||
Kozo Kuribayash | |||
P2860 | cites work | Survival after trimodality therapy for malignant pleural mesothelioma: Radical Pleurectomy, chemotherapy with Cisplatin/Pemetrexed and radiotherapy. | Q30380858 |
Extrapleural pneumonectomy or pleurectomy/decortication for malignant pleural mesothelioma | Q34130373 | ||
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma | Q34214330 | ||
Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study | Q35141809 | ||
Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest Grou | Q36990070 | ||
Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma | Q37395554 | ||
A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma. | Q38173069 | ||
Surgery for malignant pleural mesothelioma: why, when and what? | Q38193920 | ||
Relapse pattern and second-line treatment following multimodality treatment for malignant pleural mesothelioma | Q40294287 | ||
Patterns of failure after trimodality therapy for malignant pleural mesothelioma | Q40906267 | ||
Patterns of failure, toxicity, and survival after extrapleural pneumonectomy and hemithoracic intensity-modulated radiation therapy for malignant pleural mesothelioma | Q41697761 | ||
Extrapleural pneumonectomy for early stage malignant pleural mesothelioma: a harmful procedure | Q43640094 | ||
Second-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesothelioma | Q46432866 | ||
Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma | Q46674520 | ||
Recommendations for uniform definitions of surgical techniques for malignant pleural mesothelioma: a consensus report of the international association for the study of lung cancer international staging committee and the international mesothelioma in | Q48647167 | ||
FDG PET/CT patterns of treatment failure of malignant pleural mesothelioma: relationship to histologic type, treatment algorithm, and survival. | Q51617036 | ||
Pleurectomy/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma | Q83679798 | ||
P921 | main subject | pneumonectomy | Q46565 |
P577 | publication date | 2017-04-24 | |
P1433 | published in | International Journal of Clinical Oncology | Q15758148 |
P1476 | title | Post-recurrence chemotherapy for mesothelioma patients undergoing extrapleural pneumonectomy |
Search more.